Management of Lymph Nodes During Resection of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Systematic Review

Jemal, 2011, Global cancer statistics, CA: A Cancer Journal for Clinicians, 61, 69

Venook, 2010, The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective, The Oncologist, 15, 5, 10.1634/theoncologist.2010-S4-05

Aljiffry, 2009, Evidence-Based Approach to Cholangiocarcinoma: A Systematic Review of the Current Literature, J Am Coll Surg, 208, 134, 10.1016/j.jamcollsurg.2008.09.007

Bektas H, Schrem H, Kleine M, Tamac A, Vondran F, Uzunyayla S, and Klempnauer J. Primary Liver Tumours–Presentation, Diagnosis and Surgical Treatment. Liver Tumors-Epidemiology, Diagnosis, Prevention and Treatment. In Tech 2013:91–116.

Feliu, 2011, Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines, Clinical and Translational Oncology, 13, 536, 10.1007/s12094-011-0694-x

Al-Bahrani, 2013, Cholangiocarcinoma: risk factors, environmental influences and oncogenesis, Ann Clin Lab Sci, 43, 195

Ly, 2012, The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007, Ann Intern Med, 156, 271, 10.7326/0003-4819-156-4-201202210-00004

Venook, 2010, The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective, Oncologist, 15, 5, 10.1634/theoncologist.2010-S4-05

El-Serag, 2007, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis, Gastroenterology, 132, 2557, 10.1053/j.gastro.2007.04.061

Prevention C f D C a. Viral Hepatitis Surveillance-United States, 2011. 2011;

Llovet, 2005, Updated treatment approach to hepatocellular carcinoma, J Gastroenterol, 40, 225, 10.1007/s00535-005-1566-3

Ascha, 2010, The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis, Hepatology, 51, 1972, 10.1002/hep.23527

Sun, 2012, Obesity, inflammation, and liver cancer, J Hepatol, 56, 704, 10.1016/j.jhep.2011.09.020

Calle, 2003, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults, N Engl J Med, 348, 1625, 10.1056/NEJMoa021423

Polesel, 2009, The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma, Ann Oncol, 20, 353, 10.1093/annonc/mdn565

Wong, 2000, Estimating future hepatitis C morbidity, mortality, and costs in the United States, Am J Public Health, 90, 1562, 10.2105/AJPH.90.10.1562

Cho, 2010, Survival analysis of intrahepatic cholangiocarcinoma after resection, Annals of Surgical Oncology, 17, 1823, 10.1245/s10434-010-0938-y

Charbel, 2011, Cholangiocarcinoma: Epidemiology, Risk Factors, Pathogenesis, and Diagnosis, Current Gastroenterology Reports, 13, 182, 10.1007/s11894-011-0178-8

Altekruse, 2012, Hepatocellular Carcinoma Confirmation, Treatment, and Survival in Surveillance, Epidemiology, and End Results Registries, 1992–2008, Hepatology, 55, 476, 10.1002/hep.24710

Llovet, 1999, Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials, Hepatology, 29, 62, 10.1002/hep.510290145

Weinmann A, Koch S, Niederle I M, Schulze-Bergkamen H, König J, Hoppe-Lotichius M, Hansen T, Pitton M B, Düber C, Otto G, Schuchmann M, Galle P R, and Wörns M A. Trends in Epidemiology, Treatment, and Survival of Hepatocellular Carcinoma Patients Between 1998 and 2009: An Analysis of 1066 Cases of a German HCC Registry. Journal of clinical gastroenterology 2013;

Uzzau A, Pertoldeo M L, Cherchi V, Bertozzi S, Avellini C, and Soardo G. Surgical Treatment Strategies and Prognosis of Hepatocellular Carcinoma. 2013

Morimoto, 2003, Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma, J Hepatobiliary Pancreat Surg, 10, 432, 10.1007/s00534-002-0842-3

Konstadoulakis, 2008, Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome, Surgery, 143, 366, 10.1016/j.surg.2007.10.010

Choi, 2009, The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival, Ann Surg Oncol, 16, 3048, 10.1245/s10434-009-0631-1

Herman J M and Pawlik T M, Hepatocellular Carcinoma, Gallbladder Cancer, and Cholangiocarcinoma, in Radiation Oncology: An Evidence-Based Approach, J.J. Lu and L.W. Brady, Editors. 2008. p. 221–243.

Tan, 2008, Surgical Management of Intrahepatic Cholangiocarcinoma-A Population-Based Study, Ann Surg Oncol, 15, 600, 10.1245/s10434-007-9627-x

Nathan, 2012, National trends in surgical procedures for hepatocellular carcinoma: 1998–2008, Cancer, 118, 1838, 10.1002/cncr.26501

Cance, 2000, The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985–1996, Cancer, 88, 912, 10.1002/(SICI)1097-0142(20000215)88:4<912::AID-CNCR23>3.0.CO;2-T

Dodson, 2013, Intrahepatic cholangiocarcinoma: management options and emerging therapies, J Am Coll Surg, 217, 736, 10.1016/j.jamcollsurg.2013.05.021

Pawlik, 2005, Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma, Liver Transplantation, 11, 1086, 10.1002/lt.20472

Ishii T, Hatano E, Yasuchika K, Taura K, Seo S, and Uemoto S. High risk of lung metastasis after resection of hepatocellular carcinoma more than 7 cm in diameter. Surg Today 2013:1–6.

Hyder O, Marques H, Pulitano C, Marsh J W, Alexandrescu S, Bauer T W, Gamblin T C, Sotiropoulos G C, Paul A, Barroso E, Clary B M, Aldrighetti L, Ferrone C R, Zhu A X, Popescu I, Gigot J F, Mentha G, Feng S, and Pawlik T M. A Nomogram to Predict Long-term Survival After Resection for Intrahepatic Cholangiocarcinoma: An Eastern and Western Experience. JAMA Surg 2014;

de Jong, 2011, Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment, J Clin Oncol, 29, 3140, 10.1200/JCO.2011.35.6519

Morine, 2012, Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma, Surg Today, 42, 147, 10.1007/s00595-011-0057-9

Kokudo, 1999, Hepatic lymph node involvement in resected cases of liver metastases from colorectal cancer, Dis Colon Rectum, 42, 1285, 10.1007/BF02234215

Abdel-Wahab, 2010, Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver, Langenbeck’s Archives of Surgery, 395, 625, 10.1007/s00423-010-0643-0

Kitagawa, 2001, Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection, Ann Surg, 233, 385, 10.1097/00000658-200103000-00013

Shimada, 1997, The role of lymph node dissection in the treatment of gallbladder carcinoma, Cancer, 79, 892, 10.1002/(SICI)1097-0142(19970301)79:5<892::AID-CNCR4>3.0.CO;2-E

Mavros, 2012, A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma, J Am Coll Surg, 215, 820, 10.1016/j.jamcollsurg.2012.08.001

Ercolani, 2004, The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy, Ann Surg, 239, 202, 10.1097/01.sla.0000109154.00020.e0

Kobayashi, 2011, Surgical treatment of lymph node metastases from hepatocellular carcinoma, J Hepatobiliary Pancreat Sci, 18, 559, 10.1007/s00534-011-0372-y

Miwa, 2006, Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery, Journal of Gastroenterology, 41, 893, 10.1007/s00535-006-1877-z

Shimada, 2001, Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma, Br J Surg, 88, 1463, 10.1046/j.0007-1323.2001.01879.x

Sun, 2007, Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy, J Surg Oncol, 96, 37, 10.1002/jso.20772

Attias, 2014, Predicting hearing thresholds in occupational noise-induced hearing loss by auditory steady state responses, Ear Hear, 35, 330, 10.1097/AUD.0000000000000001

DerSimonian, 1986, Meta-analysis in clinical trials, Controlled Clinical Trials, 7, 177, 10.1016/0197-2456(86)90046-2

Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Statistics in Medicine, 21, 1539, 10.1002/sim.1186

Hozo, 2005, Estimating the mean and variance from the median, range, and the size of a sample, BMC medical research methodology, 5, 13, 10.1186/1471-2288-5-13

Aalaei-Andabili, 2012, Important steps for a reliable meta-analysis, The Lancet Infectious Diseases, 12, 663, 10.1016/S1473-3099(12)70200-1

Grobmyer S R, Wang L, Gonen M, Fong Y, Klimstra D, D’Angelica M, DeMatteo R P, Schwartz L, Blumgart L H, and Jarnagin W R. Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg 2006; 244:260–4.

Hashimoto, 2009, Metachronous resection of metastatic lymph nodes in patients with hepatocellular carcinoma, Hepato-Gastroenterology, 56, 788

Abe, 2002, Clinical characteristics of hepatocellular carcinoma with an extensive lymph node metastasis at diagnosis, American journal of clinical oncology, 25, 318, 10.1097/00000421-200206000-00024

Awazu, 2013, Lymphadenectomy combined with locoregional treatment for multiple advanced hepatocellular carcinoma with lymph node metastases, Kobe Journal of Medical Sciences, 59, E17

Ravaioli, 2010, Safety and prognostic role of regional lymphadenectomy for primary and metastatic liver tumors, Updates Surg, 62, 27, 10.1007/s13304-010-0008-9

Xiaohong, 2010, Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma, World J Surg, 34, 1028, 10.1007/s00268-010-0400-0

Lee, 2011, Hepatic resection for hepatocellular carcinoma with lymph node metastasis: clinicopathological analysis and survival outcome, Asian J Surg, 34, 53, 10.1016/S1015-9584(11)60020-1

Hyder, 2013, Recurrence after operative management of intrahepatic cholangiocarcinoma, Surgery (United States), 153, 811

Sulpice, 2013, Intrahepatic cholangiocarcinoma: impact of genetic hemochromatosis on outcome and overall survival after surgical resection, Journal of Surgical Research, 180, 56, 10.1016/j.jss.2012.10.051

Nanashima, 2009, Relationship Between Microvessel Count and Postoperative Survival in Patients with Intrahepatic Cholangiocarcinoma, Ann Surg Oncol, 16, 2123, 10.1245/s10434-009-0494-5

Zhou, 2009, Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma, Journal of Cancer Research and Clinical Oncology, 135, 1073, 10.1007/s00432-009-0547-y

Guglielmi, 2009, Intrahepatic Cholangiocarcinoma: Prognostic Factors After Surgical Resection, World J Surg, 33, 1247, 10.1007/s00268-009-9970-0

Shimada, 2007, Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases, J Surg Oncol, 96, 160, 10.1002/jso.20792

Tajima, 2004, An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma, Br J Surg, 91, 99, 10.1002/bjs.4366

Morimoto, 2003, Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma, Journal of Hepato-Biliary-Pancreatic Surgery, 10, 432, 10.1007/s00534-002-0842-3

Igami, 2011, Staging of Peripheral-Type Intrahepatic Cholangiocarcinoma: Appraisal of the New TNM Classification and its Modifications, World J Surg, 35, 2501, 10.1007/s00268-011-1242-0

Saxena, 2010, Clinicopathologic and Treatment-Related Factors Influencing Recurrence and Survival after Hepatic Resection of Intrahepatic Cholangiocarcinoma: A 19-Year Experience from an Established Australian Hepatobiliary Unit, Journal of Gastrointestinal Surgery, 14, 1128, 10.1007/s11605-010-1203-1

Shirabe, 2010, Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: Relevance of the lymphatic invasion index, Annals of Surgical Oncology, 17, 1816, 10.1245/s10434-010-0929-z

Portolani N, Baiocchi G L, Coniglio A, Piardi T, Grazioli L, Benetti A, Ferrari Bravo A, and Giulini S M. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience. Ann Surg Oncol 2008; 15:1880–90.

Ercolani, 2004, The role of lymphadenectomy for liver tumors - Further considerations on the appropriateness of treatment strategy, Annals of Surgery, 239, 202, 10.1097/01.sla.0000109154.00020.e0

Ribero D, Pinna A D, Guglielmi A, Ponti A, Nuzzo G, Giulini S M, Aldrighetti L, Calise F, Gerunda G E, Tomatis M, Amisano M, Berloco P, Torzilli G, Capussotti L, and Italian Intrahepatic C. Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma A Multi-institutional Analysis of 434 Patients. Archives of Surgery 2012; 147:1107–1113.

Uchiyama, 2011, Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: A multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery, Journal of Hepato-Biliary-Pancreatic Sciences, 18, 443, 10.1007/s00534-010-0349-2

Yamamoto, 1999, Lymph node metastasis in intrahepatic cholangiocarcinoma, Jpn J Clin Oncol, 29, 147, 10.1093/jjco/29.3.147

Ali, 2013, Role of major vascular resection in patients with intrahepatic cholangiocarcinoma, Annals of Surgical Oncology, 20, 2023, 10.1245/s10434-012-2808-2

Guglielmi, 2013, Patterns and Prognostic Significance of Lymph Node Dissection for Surgical Treatment of Perihilar and Intrahepatic Cholangiocarcinoma, Journal of Gastrointestinal Surgery, 17, 1917, 10.1007/s11605-013-2331-1

Li, 2009, Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma, Chin Med J (Engl), 122, 2286

Murakami, 2012, Intrahepatic Cholangiocarcinoma: Clinicopathological Differences Between Peripheral Type and Hilar Type, Journal of Gastrointestinal Surgery, 16, 540, 10.1007/s11605-011-1730-4

Shimada, 2009, Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement, Surgery, 145, 411, 10.1016/j.surg.2008.11.010

Suzuki, 2002, Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma, World J Surg, 26, 687, 10.1007/s00268-001-0291-1

Tamandl, 2009, Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma, Br J Surg, 96, 919, 10.1002/bjs.6654

Tsuji, 2001, Lymphatic spreading pattern of intrahepatic cholangiocarcinoma, Surgery, 129, 401, 10.1016/S0039-6060(01)49159-8

Uenishi, 2008, Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases, Journal of Hepato-Biliary-Pancreatic Surgery, 15, 417, 10.1007/s00534-007-1315-5

Yedibela, 2009, Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: An 11-year western single-center experience in 107 patients, Annals of Surgical Oncology, 16, 404, 10.1245/s10434-008-0227-1

Yonemori, 2010, Prognostic Impact of Regional Lymph Node Micrometastasis in Patients With Node-Negative Biliary Cancer, Annals of Surgery, 252, 99, 10.1097/SLA.0b013e3181e33c0a

Nakagawa, 2005, Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma, World J Surg, 29, 728, 10.1007/s00268-005-7761-9

Jiang, 2013, Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: A meta-analysis, J Surg Oncol, 107, 807, 10.1002/jso.23325

Pavlidis, 2011, Current opinion on lymphadenectomy in pancreatic cancer surgery, Hepatobiliary Pancreat Dis Int, 10, 21, 10.1016/S1499-3872(11)60002-7

Hueman, 2009, Evolving treatment strategies for gallbladder cancer, Ann Surg Oncol, 16, 2101, 10.1245/s10434-009-0538-x

Isa, 2001, Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma, The American journal of surgery, 181, 507, 10.1016/S0002-9610(01)00628-6

NCCN Guidelines(R) Updates. J Natl Compr Canc Netw 2013; 11:xxxii-xxxiii.

Klintmalm, 1998, Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome, Ann Surg, 228, 479, 10.1097/00000658-199810000-00005

Marsh, 2000, Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?, Cancer, 88, 538, 10.1002/(SICI)1097-0142(20000201)88:3<538::AID-CNCR7>3.0.CO;2-H

Japan L C S G o. Primary liver cancer of Japan: clinicopathological features and results of surgical treatment. Ann Surg Oncol 1990; 211:277–287.